Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Purdue Research Foundation

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$916K
Portfolio companies 10
Rounds per year 0.16
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Diagnostics
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Purdue Research Foundation:
Typical Co-investors
Purdue Research Foundation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Purdue Research Foundation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BRICOLAGE Moscow, Moscow, Russia
Bynet Data Communications Hefa, Hefa, Israel
Capricorn Management Connecticut, Greenwich, United States
Cooperative Capital Tacoma, United States, Washington
Dujiaojing Chuangye Touzi China, Ningbo, Zhejiang
Eventide Risk Management -
Immense Vantage -
Incutex Company Builders Argentina, Córdoba, Cordoba
Jado Investments California, Laguna Beach, United States
King Power International Co.,Ltd. Bangkok, Makkasan Subdistrict, Thailand
Kvika Gullbringusysla, Iceland, Reykjavík
LA ROCA Capital Germany, Hanover, Niedersachsen
ResMed California, San Diego, United States
San Francisco Equity Partners California, San Francisco, United States
Shanghai Lingyue Yunshang Chuangye Touzi China, Qingpu, Shanghai
Speee Japan, Tokyo
Strategic Equities -
Tech Startup Stabilization Fund -
White Unicorn Ventures India, Maharashtra, Mumbai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Novosteo

Health Care
Pharmaceutical
$5M13 Jan 2021 Pennsylvania, United States

ClearBlade

Cloud Computing
Cyber Security
Enterprise Software
Internet of Things
Software
15 Dec 2020 Austin, Texas, United States

Animated Dynamics

Biotechnology
Health Diagnostics
Medical
$250K28 May 2019 Indianapolis, Indiana, United States

Novosteo

Health Care
Pharmaceutical
$250K20 Dec 2018 Pennsylvania, United States

Brightlamp

Computer Vision
Health Diagnostics
Medical
Software
$20K05 Dec 2016 Indiana, United States

Animated Dynamics

Biotechnology
Health Diagnostics
Medical
$1M16 Jun 2016 Indianapolis, Indiana, United States

SPEAK MODalities

Education
Health Care
Mobile
Mobile Apps
Software
$50K20 Jan 2016 West Lafayette, Indiana, United States

Vemo Education

Education
Financial Services
FinTech
Higher Education
23 Nov 2015 Arlington, Virginia, United States

Animated Dynamics

Biotechnology
Health Diagnostics
Medical
08 Oct 2014 Indianapolis, Indiana, United States
News
Novosteo Closes $5.5M in Series A Financing

– Novosteo Closes $5.5m in Series A Financing.
– The company raised $5.5m in Series A financing.
– The round was led by Kairos Ventures, as well as BioCrossroads Ventures, Elevate Ventures and Purdue Research Foundation.
– Proceeds from the financing will be used to advance NOV004 into clinical development that will begin in the first half of 2021.

Research Bridge Partners' Portfolio Company, Novosteo, Inc., Closes $5.5 Million in Series A Financing

– Research Bridge Partners announced that one of its portfolio companies, Novosteo, Inc., closed $5.5m in Series A financing to further development of the first-ever targeted bone anabolic agent NOV004.
– The round was led by Kairos Ventures, as well as BioCrossroads Ventures, Elevate Ventures and Purdue Research Foundation.
– Novosteo, Inc.’s NOV004 has shown promise in live animals in the acceleration of fracture healing when delivered systemically.
– Proceeds from the financing will be used to advance NOV004 into clinical development that will begin in the first half of 2021.
– Bone injuries and disease are one of the most challenging health issues facing all ages, especially for the elderly.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Purdue Research Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: